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Introduction: Liponeurocytomas are mostly localized in cerebellar hemispheres and the
second most common location is the vermis. It is rarely observed within the intracranial
ventricles. Here, we present a case of liponeurocytoma located in the right lateral ventricle
and the systematic review of the literature.
State of the art: We searched PubMed with keyword 'central liponeurocytoma' and the
references of the related articles. There were no language or year restrictions. We included
articles focusing on liponeurocytomas located in the central nervous system leaving a total
of 17 articles and 21 reported cases [2_TD$DIFF].
Clinical implications: A 62-year-old female presented with confusion and mental disorienta-
tion without any other neurological deﬁcit. Her magnetic resonance imaging (MRI) revealed
a lateral ventricle located mass lesion which was hypointense on T1-weighted images (WI)
and heterogeneously hyperintense on T2-WI with cystic component. Via craniotomy,
yellow-beige colored, soft and moderately vascularized mass lesion was gross totally
resected. Despite postoperative MRI revealed total resection, patient had left-sided hemi-
paresis. The patient recovered well in her postoperative period and there was no recurrence
on her 6th month follow-up MRI.
Future directions: Intraventricular liponeurocytoma has a favorable clinical course, and
radiological features may be useful in the diagnosis of this rare tumor before surgery.
Supratentorial intraventricular location should be kept in mind in the differential diagnosis
of the lateral ventricular tumors.
© 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.* Corresponding author.
E-mail address: pnr.kuru@gmail.com (P. Kuru Bektaşoğlu).
https://doi.org/10.1016/j.pjnns.2018.09.001
0028-3843/© 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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The cerebellar liponeurocytoma is a rare, well-differentiated
neuronal and variable astrocytic tumor of the central nervous
system (CNS) that arises in adults and typically shows focal or
regional lipomatous differentiation [1]. Liponeurocytomas are
predominantly localized in cerebellar hemispheres and the
secondmost common location is the vermis. It is occasionally
located in supratentorial lateral ventricle and the fourth
ventricle [2,3]. To the best of our knowledge, 47 cases in the
cerebellum, 15 cases in the lateral ventricle, 2 cases in the 3rd
ventricle and 2 cases in the 4th ventricle had been reported [3–
5]. Due to the limited number of cases, little is knownabout the
supratentorial intraventricular liponeurocytoma when com-
pared to the cerebellar form [3]. Because of its rarity and lack of
long-term follow-up data, the biological behaviors and clinical
features of this tumor are still not well understood. In recent
years, it is indicated that patients with cerebellar liponeur-
ocytomas usually show a desirable clinical course after
neurosurgical removal, which means that the correct diagno-
sis is very important in order to avoid unnecessary adjuvant
therapy. Here, we present a 62-year-old woman with right
lateral ventricular liponeurocytoma with a detailed review of
literature of liponeurocytomas located in supratentorial areas.
1.1. Literature search
We searched PubMed with keyword 'central liponeurocytoma'
and the references of the related articles. There were no
language or year restrictions. We included articles focusing on
liponeurocytomas located in the CNS, leaving a total of 17
articles and 21 reported cases. The PRISMA ﬂowchart for the
[(Figure_1)TD$FIG]
Figure 1 – Axial (A), T1-weighted (B), T2-weighted (C), T1-weigh
T2-weighted (F), coronal T1-weighted contrast-enhanced MRI re
lobulated contour and heterogeneously hyperintense cystic com
heterogeneous contrast enhancement at the central part.elimination of the articles is shown in the Supplementary
Checklist.
1.2. Case description
A 62-year-old female patient presented with confusion and
mental disorientation without any other neurological deﬁcits.
In her previous medical history, she had bilateral adrenelect-
omy, diagnosed as Cushing disease 22 years ago, under
medication, operated 1 year ago for colon cancer, and took
chemotherapy. There was no active comorbidities or evidence
of organ failure at the time of the surgery. Magnetic resonance
imaging (MRI) revealed 49  33  31 mm lobulatedmass lesion
located at the right lateral ventricle also expanding through
the left side of the midline. Lesion was hypointense on T1-WI
and heterogeneously hyperintense on T2-WI with cystic
component. On T1-WI, hemorrhagic component was seen at
the lateral part of the lesion. There was heterogeneous
contrast enhancement at the central part (Fig. 1). The patient
underwent interhemispheric transcallosal approach via right-
sided craniotomy formicrosurgical resection of the lesion. The
lesion was yellow-beige colored, soft suckable andmoderately
vascularized. Gross total resection was achieved. Despite
postoperative MRI revealed total resection, patient had left-
sided hemiparesis. It is thought that postoperative hemipar-
esis is possibly caused by interhemispheric retraction. Hemi-
paresis was resolved with the aid of physiotherapy gradually
within 6 months. The patient recovered well in her postoper-
ative period, and there was no recurrence on her 6th month
follow-up MRI. The pathological diagnosis was liponeurocy-
toma WHO grade II. Histopathological examination of the
tumor tissue revealed no nuclear atypia, no mitosis, no
hypercellularity and no necrosis. Round or oval nucleus, thinted contrast enhanced (D), sagittal T2-weighted (E), coronal
vealed mass lesion located at right lateral ventricle with
ponent. Contrast-enhanced sequences revealed
[(Figure_2)TD$FIG]
Figure 2 – (A) Photomicrograph of tumor tissue with hematoxylin and eosin stain showing round or oval nucleus, thin
chromatin, mostly clear cytoplasmic diffuse proliferation (200Tmagnification). (B) Single or multiple adipocyte like lipidized
cells were observed (200T magnification). Immunohistochemical evaluation was early and mature neuronal markers
positive such as (C) GFAP (400T magnification), (D) synaptophysin (200T magnification) and (E) NSE (200T magnification).
(F) There was no staining with P53 (200T magnification).
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 6 7 0 – 6 7 6672chromatin,mostly clear cytoplasmic diffuse proliferationwere
observed (Fig. 2). Single or multiple adipocytes like lipidized
cells were observed. Immunohistochemical evaluation was
positive for early and mature neuronal markers, such as glial
ﬁbrillary acidic protein (GFAP), synaptophysin and neuron-
speciﬁc enolase (NSE). Epithelial membrane antigen (EMA),
cromogranin A and P53 were negative. In our case, she had
multiple systemic diseases and died 1 year after surgery due to
multiple organ dysfunctions. Case reports and review articles
are exempt from ethical commitee approval in our institution.
The informed consent is obtained frompatient and her family.
2. DiscussionLiponeurocytomas are rare benign CNS neoplasms with a
favorable clinical prognosis [6]. The peak incidence is from 30
to 60 years old, and the mean age is approximately 53 years.
Men and women are equally affected [7]. This tumor type has
low proliferative potential, especially when compared to
medulloblastoma, the primitive neuroectodermal tumor ofthe cerebellum from which the liponeurocytoma needs to be
distinguished [8]. However, recurrence may occur and malig-
nant progression had been reported. The tumor is mainly
involved in cerebellar hemisphere, but can also be located in
the paramedian region or vermis and extend to the cerebello-
pontine angle or fourth ventricle [7]. Limiting the occurrence of
liponeurocytoma unnecessarily to cerebellum obscures the
presence of similar neoplasms at the other locations. Twenty-
one intraventricular liponeurocytoma cases had been reported
in the literature [2,3]. We herein present a 62-year-old woman,
the 22nd example of intraventricular liponeurocytoma with a
review of the literature. Detailed review of intraventricular
liponeurocytoma cases were presented in Table 1.
The main clinical presentations such as headache and
vomiting were usually related to increased intracranial
pressure due to mass effect and hydrocephalus [3]. Our case
presented with mental disorientation and confusion. On CT,
the tumor is variably isodense or hypodense, with focal areas
of marked hypoattenuation corresponding to fat density [7,9].
On T1-WI, the tumor is isointense to hypointense, with patchy
areas of hyperintensity corresponding to regions of high lipid
Table 1 – Clinical summary of 12 reported cases of cerebral liponeurocytomas.
Authors Age/sex Clinical features Site Imaging ﬁndings Treatment Prognosis
Horoupian et al.,
1997 [27]
30 years/M Headache for 3 months,
nausea, vomiting, blurred
vision during the past few
weeks, bilateral grade III
papilledema with 10/70 visual
acuity and enlargement of
blind spots
Left lateral ventricle, 3rd
ventricle, corpus callosum
CT and MRI of the brain showed a
5.0  4.0  3.5 cm deep,
nonhomogenous mass with mixed
signals indicating the presence of fat
and possibly calcium. The tumor ﬁlled
the left lateral ventricle and extended
rostrocaudally over the length of the
body of the corpus callosum and roof
of the 3rd ventricle encroaching into
the periventricular white matter. Both
lateral ventricles were dilated
Subtotal resection Five months after surgery, the
patient had mild weakness of
dorsi- and plantar ﬂexion of the
right foot and moderate
memory deﬁcits and motor
apraxia. His vision recovered
almost fully on the left but
partially on the right. He was
subsequently lost to follow-up
George et al.,
2001 [19]
59 years/F - Anterior horn, left lateral
ventricle
— — —
Rajesh et al.,
2003 [21]
30 years/M Headache, instability of gait for
3 months. Right-sided
cerebellar signs and VI cranial
nerve paresis
Frontal horn, lateral ventricle MRI revealed a mass lesion measuring
7.8  6.7  6 cm in the body and
frontal horn of the lateral ventricle.
The lesion was inﬁltrating the corpus
callosum
Near total excision Postoperatively, the patient
developed massive
intraventricular bleeding on the
third day and died
Kuchelmeister
et al., 2006 [24]
35 years/M — Left lateral ventricle — — —
Aytaç et al., 2009
[30]
55 years/F Headache 3 years, amnesia,
dizziness
Left lateral ventricle MRI: iso-heterogeneous intensity on
T1-WI and hyperintense on T2-WI
Gross total
resection
Not speciﬁed
Pankaj et al.,
2010 [25]
35 years/M Intermittent severe headache
associated with blurring of
vision and diplopia for 6
months, generalized weakness.
Bilateral papilledema and
bilateral 6th nerve palsy
Lateral horn, right lateral
ventricle
MRI brain scan revealed an
inhomogeneously enhancing large
intraventricular mass ﬁlling the body
and lateral horn of right ventricle
The mass measured 5  3  1 cm and
showed areas of calciﬁcation
Gross total
resection
Patient required a
ventriculoperitoneal shunt on
the 10th post-operative day. His
subsequent recovery was
satisfactory and at the time of
discharge his Glasgow coma
scale score was 14
Chakraborti
et al., 2011 [22]
36 years/M Bifrontal headache: 4 months,
blurring of vision: 15 days.
Bilateral papilledema
Bilateral lateral ventricle CT: mixed density, irregular mass
lesion, bilateral lateral ventricles
causing hydrocephalus. Third and 4th
ventricles normal
Radical excision Recurrence 9 years and 4
months later. Re-exploration
and radical excision of the
tumor performed with
postoperative radiotherapy.
No recurrence at 2-year follow-
up
30 years/M Intermittent, holocranial
headache and vomiting for 2
years. Bilateral papilledema
Lateral and 3rd ventricle CT: irregular, hypodense lesion
occupying both the lateral and 3rd
ventricles. MRI: lesion was
hyperintense on T1-WI and T2-WI
images with specks of hypointensity
Gross total
resection
Post-operative period was
uneventful and the patient was
lost for follow-up
32 years/M Intermittent, holocranial
headache, left lower limb
weakness for 6 months.
Bilateral papilledema
Bilateral lateral ventricle,
central
CT: hyperdense, irregular, lobulated,
minimally enhancing mass lesion, in
the septal area extending into both
lateral ventricles, asymmetrically
causing hydrocephalus
Gross total
excision
Post-operative period was
uneventful and the patient was
lost for follow-up
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Table 1 (Continued )
Authors Age/sex Clinical features Site Imaging ﬁndings Treatment Prognosis
den Hollander
et al., 2011 [31]
43 years/M — Right lateral ventricle — Gross total
resection
Not speciﬁed
Gupta et al.,
2011 [23]
45 years/M — Trigone of lateral ventricle — — —
Ding et al., 2014
[32]
52 years/F Headache for 10 days Third ventricle CT: round hypodense lesion with dark
area suggestive of fatty tissue, and
also speckled calciﬁcation
Gross total
resection
No recurrence at 10 months,
and the patient was lost for
follow-up
Karabagli et al.,
2014 [2]
34 years/M Headache Third ventricle On T1-WI showed a large, partly
cystic, 4  5 cm mass in the 3rd
ventricle with heterogeneous
enhancement with gadolinium
Gross total
resection
No recurrence at 2 years
Ruiz Ginés et al.,
2014 [33]
33 years/M Crural sensitive symptoms,
recent onset headache
Supratentorial, tumor Intraventricular, multicystic,
heterogeneous and with areas of
associated lipomatosis
Gross total
resection
Not speciﬁed
Wang et al.,
2016 [34]
30 years/M Headache dizziness for 1
months
Right lateral ventricle CT: slightly hypodense round lesion
with small cystic areas
Gross total
resection
Not mentioned
Xu et al., 2017 [3] 29 years/M Headache for 3 months,
vomiting
Right lateral ventricle CT: an isodense to slight hyperdense
round mass; MRI: heterogeneous
intensity on T1-WI and T2-WI
Gross total
resection
No recurrence at 2 years
48 years/F Headache for 12 months,
numbness
Forth ventricle MRI: an irregular mass with
isointensity on T1 and T2-WI, several
microcysts and slight enhancement
on contrast.
Gross total
resection
No recurrence at 5 years
Shi et al., [3] 36 years/M Headache dizziness for 12
months
Left lateral ventricle CT: hypo-to isodense mass lesion.
MRI: isointense on T1-WI and T2-WI,
short T1 hyperintense displayed on
T1-WI
Gross total
resection
No recurrence at 2.5 years,
and the patient was lost for
follow-up
Xu et al., 2017
[35]
29 years/M Right lateral ventricle Headache (1 month). Physical
and neurological examinations
unremarkable
MRI: a well-demarcated solid lesion
with multiple small cysts and
moderate heterogeneous
enhancement
No perilesional edema
Gross total
resection
No recurrence at 1 year and 5
months
Cai et al., 2018
[36]
11 years/M Intermittent headache, nausea
and vomiting
Right cerebral hemisphere CT: An irregular hypodense and
isodense mixed mass in the right
frontal lobe
MRI: A large cystic—solid mass
approximately 4.5  4.7  6.4 cm in
size, in the right frontal lobe. The solid
part of the mass exhibited
heterogeneous isointensity on T1-WI
and T2-WI
Gross total
resection
No clinical or neuroradiological
evidence of recurrence or
residual of the tumor was found
6 years and 2 months after
initial surgery
CT, computed tomography, FLAIR, ﬂuid attenuated inversion recovery, FSE, fast spin echo; MRI, magnetic resonance imaging, WI, weighted imaging.
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may not reveal this hyperintensity on T1-WI because of
different content of fat tissue within the tumor. The
hyperintensity on T1-WI reﬂecting fat within the tumor can
be suppressed to hypointensity in fat-suppression sequence.
This signal intensity change may be useful in determining a
preoperative diagnosis of liponeurocytoma [9]. MRI ﬁndings of
the tumor of our case were hypointense on T1-WI, and
hemorrhagic component was seen at the lateral part of the
lesion. Enhancement with gadolinium is usually heteroge-
neous, with areas of tumor showing variable degrees of
enhancement implying mild vascularity in intraventricular
liponeurocytomas. In addition, several microcysts were also
clearly displayed on T1- and T2-WI. There was heterogeneous
contrast enhancement at the central part in our case. On
T2-WI, the tumor is slightly hyperintense to the adjacent
brain, with focal areas of marked hyperintensity. Our case was
also heterogeneously hyperintense on T2-WI with cystic
component. Associated edema is usually minimal or absent
[10]. On diffusion-weighted images, the non-fat component
of the tumors revealed mildly restricted diffusion, which
reﬂected the histopathological features of the tumors such as
small tumor cells, less cytoplasm and closely arranged tissue
cells.
Cerebellar liponeurocytomas have been included in the
2000 World Health Organization (WHO) classiﬁcation of
tumors of the CNS, under the heading of glioneuronal tumors,
grade I neoplasm; the 2007 WHO classiﬁcation assigns
cerebellar liponeurocytoma to WHO grade II in light of low
proliferation but high likelihood of tumor recurrences [6,11,12].
In 2016 WHO classiﬁcation, cerebellar liponeurocytoma was
also accepted as grade II histopathologically recurrences [6]. As
many as 50–60% of these tumors will recur within periods
ranging from 1 to 12 years [6,13,14]. The time to clinical
progression is often long (mean: 6.5 years), but in some cases
relapse occurswithin a fewmonths [15]. There are currently no
accepted histologic features of liponeurocytoma that can
distinguish tumors according to recurrence risk.
In histological examination, isomorphic small neurocytic
cells arranged in sheets and lobules and with regular round to
oval nuclei, clear cytoplasm and poorly deﬁned cell mem-
branes. Focal lipomatous differentiation could also be seen [3].
The histological hallmark of this entity is focal accumulation
of lipid-laden cells that resemble adipocytes but constitute
lipid accumulation in neuroepithelial tumor cells. Features of
anaplasia such as nuclear atypia, necrosis and microvascular
proliferation are typically absent in primary lesions, but may
be found in recurrent tumors with increased mitotic activity,
an increased ki-67 proliferation index [3,16,17]. Similarly, the
lipidized component may bemarkedly reduced or even absent
in recurrent lesions [17]. Immunohistochemical staining
demonstrated both neuronal and glial differentiation. The
tumor cells and lipidized cells of liponeurocytoma may
express the neuronal markers such as synaptophysin, NSE
and microtubule-associated protein 2 (MAP-2). Focal GFAP
expression by tumor cells, which indicates astrocytic differ-
entiation, is observed in most cases [18]. Expression of glial
markers like GFAP and S-100 are limited to scattered reactive
astrocytes [19–21] and a few tumor cells [22–25]. Conveniently,
this tumor may have been derived from pluripotentialembryonic ectomesenchymal stem cells of neural crest
probably persisting in the ventricular matrix and the external
granular layer [10,26,27]. Apart from the cerebellar and
supratentorial liponeurocytoma, it should be emphasized that
the fact about lipidization within the neuroectodermal tumors
of the CNS includes cerebellar astrocytomas, multiple intrasp-
inal low-grade astrocytoma, frequently in pleomorphic
xanthoastrocytoma, occasionally in glioblastoma, ependymo-
mas and supratentorial PNET [22].
Gross total resection is the golden standard of the
treatment. In our case,we also performed gross total resection.
Repeat surgerymay be preferable to radiotherapy for recurrent
liponeurocytoma [3]. But it is unclear whether radiotherapy
should be given for recurrent tumor occurred aftermany years
of initial neurosurgery [7,28]. The related reports suggested
that the 5-year survival rate of cerebellar liponeurocytomawas
48%, but this should be interpretedwith caution because of the
paucity of long-term follow-up data [2,11,22]. There are two
main surgical approaches for intraventricular neurocytomas
including transcortical and transcallosal approaches. Trans-
callosal approach provides a shorter and more anatomical
pathway to the tumor while avoiding the injury to the normal
brain cortex. Moreover, transcallosal approach introduces
more ﬂexible and direct midline anatomical orientation to the
surgeon. Furthermore, some authors reported that the
transcallosal approach has better extent of tumor resection
and lower incidence of postoperative complications [29].
During transcallosal approach, gene of the internal capsule,
which is located lateral to the foramenofMonro should be kept
inmind and avoided from injury. Injury to the genu, directly by
retraction, might be the reason for transient or permanent
hemiparesis, as in our case.
3. ConclusionIntraventricular liponeurocytoma has distinctive morphologic
and immunophenotypic features. It should be kept in mind
that liponeurocytomas are not restricted only to the cerebel-
lum, but may infrequently be located in supratentorial
intraventricular areas as well. Larger studies based on long-
term follow-up are needed in order to clarify clinical features
and prognosis of liponeurocytoma.
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